Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process
Sponsor: Johnson & Johnson Vision Care, Inc.
Terminated
This study was terminated due to the released lenses not representing what will be made commercially available and thus the objectives could not be met
Other terminated trials from Johnson & Johnson Vision Care, Inc.
- Visual Acuity · Phase NA · Jan 2021
- Dry Eye · Phase NA · Jan 2019
- Refractive Error · Phase NA · Aug 2013
- Myopia · Phase NA · Mar 2008
More terminations from Johnson & Johnson Vision Care, Inc.
Listed as NCT03605303, this NA trial focuses on Refractive Error Correction and remains terminated or withdrawn. Sponsored by Johnson & Johnson Vision Care, Inc., it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Feb 2020 — Nov 2020 [monthly]
Terminated NA
-
Sep 2019 — Feb 2020 [monthly]
Terminated NA
-
Aug 2019 — Sep 2019 [monthly]
Terminated NA
Status: Withheld → Terminated · Phase: None → NA
-
Sep 2018 — Aug 2019 [monthly]
Withheld
-
Aug 2018 — Sep 2018 [monthly]
Withheld
First recorded
Jul 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Vision Care, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .